Investigation of oral bromelain supplementation on the healing of skin flap reconstruction after Mohs micrographic surgery (MMS) for non-melanoma skin cancers (NMSCs).
- 2026-05-14
- RCT · n = 60
- BMC surgery 26(1)
- Ehsanollah Rahimi-Movaghar
- Amir Ehtemami
- Melina Ghaneiyan
- Tahmineh Tahouri
- Sahand Hedayati Omami
- Hila Fahimi
- PubMed: 42135693
- DOI: 10.1186/s12893-026-03820-4
- High evidence
- Clinical
Other outcomes, including inflammation, pain, and cosmetic satisfaction, showed non-significant trends favoring bromelain.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 1500 mg/day